Oramed Pharmaceuticals Inc.
ORMP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $52 | $16 | $75 | $54 |
| Short-Term Investments | $83 | $82 | $56 | $88 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $136 | $99 | $131 | $143 |
| Property Plant & Equip (Net) | $1 | $3 | $2 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $83 | $57 | $10 | $11 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $3 | $4 | $0 |
| Total NC Assets | $84 | $63 | $16 | $12 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $220 | $162 | $148 | $155 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $3 | $0 | $4 | $3 |
| Deferred Revenue | $1 | $1 | $0 | $0 |
| Other Curr. Liab. | $1 | $1 | $1 | $1 |
| Total Curr. Liab. | $6 | $4 | $5 | $6 |
| LT Debt | $1 | $1 | $0 | $0 |
| Deferred Rev, NC | $3 | $4 | $2 | $4 |
| Deferred Tax Liab, NC | $8 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $12 | $4 | $2 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $0 | $0 |
| Total Liabilities | $18 | $8 | $8 | $10 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$123 | -$171 | -$184 | -$177 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $325 | $325 | $325 | $645 |
| Total Equity | $203 | $155 | $141 | $146 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1 | -$1 | -$1 | -$1 |
| Total Liab. & Tot. Equity | $220 | $162 | $148 | $155 |
| Net Debt | -$51 | -$15 | -$74 | -$54 |